Biotech

Categories
LTP Special Column (237) Fintech (23) Blockchain / Digital Asset (5) ESG (24) Mergers & Acquisitions / Cross-border Investment (11) Capital Market / Securities (249) General Corporate Affairs (154) Infrastructure Projects / Construction Laws (106) Trade Secret (18) Trademark (45) Patent (31) Copyright (78) Competition Law (80) Biotech (32) Energy (13) Media / Entertainment (55) Employment Law (118) Personal Data Protection (38) Arbitration / Litigation (329) Tax (56) Environmental Protection Law (8) PRC Investment and Legal Compliance (34) Other Areas (231)

September 2022

Sub-laws of the Act for the Development of Biotech and Pharmaceutical Industry Enacted and Promulgated by the MOEA and the MOF of Taiwan

September 2022

Reflection on the Benefit Sharing Mechanism for Providers of Specimens or Biological Data in Regenerative Therapy Research (Taiwan)

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (VI) –The MOEA of Taiwan Pre-announced Draft Sub-law: Regulations Governing Management of Research Personnel’s Concurrent Holding of Jobs and Investments by Contribution of Technology to Start-up Biotech and Pharmaceutical Company

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (V) –The Draft Regulations Announced by the MOEA and MOF of Taiwan: Regulations Governing the Tax Deferral for a Top Executive or Technology Investor in Biotech and Pharmaceutical Companies, Regulations Governing Biotech and Pharmaceutical Companies' Issuance of Stock Options, and Regulations Governing Application of Deferred Taxation of Income Tax in Accordance with the Act for the Development of Biotech and Pharmaceutical Industry

July 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (IV) –The MOEA of Taiwan Announced the Regulatory Highlights of the Drafts Concerning the Tax Credits for the Income from Investment in Biological or Pharmaceutical Companies by Profit-seeking Enterprises or Individuals

July 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (III) – The Draft Regulations Governing the Applicability of Investment Tax Credits to Biotech and Pharmaceutical Companies’ Investments in Machinery, Equipment or Systems, Which Is the Sub-law Pre-announced by the MOEA of Taiwan

July 2022

Regulations for the Implementation of the Drug Administration Law (Draft Revision for Comments) in Mainland China Focused Interpretation

July 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (II) – the Draft Regulations Governing the Applicability of Investment Tax Credits to Biotech and Pharmaceutical Companies' Research and Development Expenditures, Which Is the Sub-law Pre-announced by the MOEA of Taiwan

June 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (I) ─ Implementation Highlights of the Act for the Development of Biotech and Pharmaceutical Industry and the Draft Regulations Governing the Approval of Biotech and Pharmaceutical Companies, Which Is the Sub-law Pre-announced by the MOEA of Taiwan

March 2022

Summary of the Draft Amendments to Taiwan MOHW's Scientific and Technological Research and Development Results Ownership and Utilization Regulations
< 1 2 3 4 >